Oritavancin

Paul G. Auwaerter, M.D., Kathryn Dzintars, PharmD, BCPS

INDICATIONS

FDA

  • Acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive organisms

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 19, 2022